| 000 | 01596 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517141228.0 | ||
| 264 | 0 | _c20181011 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a2190-3948 | ||
| 024 | 7 |
_a10.1007/s13346-017-0364-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Gajanand | |
| 245 | 0 | 0 |
_aLanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB/c mice model. _h[electronic resource] |
| 260 |
_bDrug delivery and translational research _c04 2018 |
||
| 300 |
_a398-413 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAminoquinolines |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 |
_aExcipients _xadministration & dosage |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aImiquimod |
| 650 | 0 | 4 |
_aKeratolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKeratosis _xchemically induced |
| 650 | 0 | 4 |
_aLanolin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aSalicylic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 | _aSkin Absorption |
| 700 | 1 | _aDevi, Neelam | |
| 700 | 1 | _aThakur, Kanika | |
| 700 | 1 | _aJain, Ashay | |
| 700 | 1 | _aKatare, O P | |
| 773 | 0 |
_tDrug delivery and translational research _gvol. 8 _gno. 2 _gp. 398-413 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s13346-017-0364-9 _zAvailable from publisher's website |
| 999 |
_c26903052 _d26903052 |
||